mepolizumab/benralizumab Flashcards
1
Q
main indication
A
add on in uncontrolled moderate/severe eosinophilic asthma
2
Q
mechanism of action
A
block the effects of IL-5 - main cytokine involved in activation of eosinophils
3
Q
administration
A
injection every 4/8 weeks ( expensive )